PATENT CLAIM ANALYSIS

Application Number: 16017836
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "060000"]

Abstract:
What is described is a method for treating cancer in a patient in need of such treatment through the use of a dual CXCR1/2 antagonist by administering a therapeutically effective amount of a dual CXCR1/2 antagonist, or pharmaceutical compositions thereof, either alone as monotherapy, or in combination with at least one other anticancer therapy.

Claim (Index 19):
The method of  claim 1 , wherein the cancer is a glioblastoma.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 94.0
- Lexical Diversity: 1.34884
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15354936', '15903503', '15627766', '14610960', '13957665']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.659417993539793
- 35 USC 102 Novelty (BERT): 0.6456242821829193
- Combined Prediction Score: 0.6580386224041057
- Mean Citation Score: 491.560178
- Max Citation Score: 633.99786
- Similarity Product: 572.8913731105721

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test